Back to Market Feed

Product Information

SEVELAMER HCL 800 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.7025 per EA under NDC 59651008818. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on Jul 11, 2023. Its Orange Book therapeutic-equivalence code is BX.

SEVELAMER HCL 800 MG TABLET

SEVELAMER HYDROCHLORIDE
$0.7025per EA

Strength

800 mg/1

NDC

59651008818

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SEVELAMER HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212599

FDA Approved

7/11/2023

TE Code

BX

On Market Since

7/11/2023

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for SEVELAMER HCL 800 MG TABLET has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 69.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7025 per EA
All-time high$2.3333 (Nov 15, 2023)
All-time low$0.7025 (Aug 19, 2026)
52-week high$1.3679
52-week low$0.7025
Median price$1.2909
Average price$1.3429
Largest weekly change-37.7% (May 22, 2024)
Weeks tracked146
Tracking sinceNov 8, 2023

Price History

1W

-3.0%

1M

-3.0%

3M

-9.2%

6M

-25.8%

1Y

-48.6%

3Y

N/A

5Y

N/A

All

-69.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SEVELAMER HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

LACTATED RINGERS INJECTION
Generic
00338011704•Baxter Healthcare Corporation
$0.0020
per ML
LACTATED RINGERS INJECTION
Generic
00264775000•B. Braun Medical Inc.
$0.0038
per ML
LACTATED RINGERS INJECTION
Generic
00264775007•B. Braun Medical Inc.
$0.0038
per ML
LACTATED RINGERS INJECTION
Generic
00264775010•B. Braun Medical Inc.
$0.0038
per ML
LACTATED RINGERS INJECTION
Generic
00338011703•Baxter Healthcare Corporation
$0.0038
per ML
LACTATED RINGERS 1,000 ML
Generic
00338960012•Baxter Healthcare Corporation
$0.0038
per ML
LACTATED RINGERS INJECTION
Generic
00990795303•ICU Medical Inc.
$0.0038
per ML
LACTATED RINGERS INJECTION
Generic
00990795309•ICU Medical Inc.
$0.0038
per ML
CALCIUM CARB 500 MG TAB CHEW
Generic
69618002015•Reliable 1 Laboratories LLC
$0.0129
per EA
QC ANTACID 500 MG CHEW TABLET
Generic
63868004715•Chain Drug Marketing Association
$0.0134
per EA

Frequently asked questions

What is the NADAC price of SEVELAMER HCL 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.7025 per EA (NDC 59651008818), effective Aug 19, 2026.

How has the price of SEVELAMER HCL 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 69.9%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?

Since Nov 8, 2023, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7025 (Aug 19, 2026) to a high of $2.3333 (Nov 15, 2023), with a median of $1.2909 per EA.

Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of SEVELAMER HCL 800 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SEVELAMER HCL 800 MG TABLET?

SEVELAMER HCL 800 MG TABLET (NDC 59651008818) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.